NASDAQ: ADXNAddex Therapeutics Ltd Stock Ownership - Who owns Addex Therapeutics?
Insider buying vs selling
Have Addex Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ADXN insiders and whales buy or sell their stock.
ADXN Shareholders
What type of owners hold Addex Therapeutics Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Timothy Mark Dyer | 17.14% | 16,848,979 | $112.89M | Insider |
| Vincent Michael Lawton | 2.55% | 2,507,987 | $16.80M | Insider |
| Raymond George Hill | 1.39% | 1,365,532 | $9.15M | Insider |
| Roger Mills | 0.80% | 785,976 | $5.27M | Insider |
| Mikhail Kalinichev | 0.31% | 306,765 | $2.06M | Insider |
| Jason Raleigh Nunn | 0.22% | 219,561 | $1.47M | Insider |
| Isaac Manke | 0.22% | 219,561 | $1.47M | Insider |
| Morgan Stanley | 0.00% | 300 | $2.01k | Institution |
| Ubs Group Ag | 0.00% | 156 | $1.05k | Institution |
| Gamma Investing LLC | 0.00% | 81 | $542.70 | Institution |
ADXN vs Biotech Stocks
Addex Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.